|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print March 27, 2002
Am J Physiol Cell Physiol, 10.1152/ajpcell.00261.2001
Submitted on June 12, 2001
Accepted on March 20, 2002
1 Institut de recherches cliniques de Montreal, Montreal, Quebec, Canada
2 Pharmacology, University of Montreal, Montreal, Quebec, Canada
3 Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
4 Institut de recherches cliniques de Montreal, Montreal, Quebec, Canada; Pharmacology, University of Montreal, Montreal, Quebec, Canada
* To whom correspondence should be addressed. E-mail: melochs{at}ircm.qc.ca.
The epidermal growth factor receptor (EGFR) was recently identified as a signal transducer of G protein-coupled receptors (GPCRs). In this study, we have examined the contribution of EGFR transactivation to the growth-promoting effect of GPCRs on vascular smooth muscle cells. Activation of the Gq-coupled angiotensin II receptor or Gi-coupled lysophosphatidic acid receptor resulted in increased tyrosine phosphorylation and activation of EGFR. Specific inhibition of EGFR kinase activity by tyrphostin AG1478 or expression of a dominant-negative EGFR mutant abolished this response. Importantly, inhibition of EGFR function strongly attenuated the global stimulation of protein synthesis by GPCR agonists in vitro in cultured aortic smooth muscle cells and in vivo in the rat aorta and in small resistance arteries. The growth inhibition was associated with a marked reduction of extracellular signal-regulated kinase and phosphoinositide 3-kinase pathways activity, and the resulting suppression of eukaryotic translation initiation factor 4E and 4E-binding protein 1 phosphorylation. Our results demonstrate that EGFR transactivation is a physiologically relevant action of GPCRs linked to translational control and protein synthesis.
This article has been cited by other articles:
![]() |
E. R. Olson, P. E. Shamhart, J. E. Naugle, and J. G. Meszaros Angiotensin II-Induced Extracellular Signal-Regulated Kinase 1/2 Activation Is Mediated by Protein Kinase C{delta} and Intracellular Calcium in Adult Rat Cardiac Fibroblasts Hypertension, March 1, 2008; 51(3): 704 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhou, B. O. Ibe, and J. U. Raj Platelet-activating factor induces ovine fetal pulmonary venous smooth muscle cell proliferation: role of epidermal growth factor receptor transactivation Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2773 - H2781. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Dao, C. Bouvet, S. Moreau, P. Beaucage, R. Lariviere, M. J. Servant, J. de Champlain, and P. Moreau Endothelin is a dose-dependent trophic factor and a mitogen in small arteries in vivo Cardiovasc Res, July 1, 2006; 71(1): 61 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. V. Yosypiv, M. Schroeder, and S. S. El-Dahr Angiotensin II Type 1 Receptor-EGF Receptor Cross-Talk Regulates Ureteric Bud Branching Morphogenesis J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1005 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vecchione, E. Patrucco, G. Marino, L. Barberis, R. Poulet, A. Aretini, A. Maffei, M. T. Gentile, M. Storto, O. Azzolino, et al. Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3K{gamma} J. Exp. Med., April 18, 2005; 201(8): 1217 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Olson, J. E. Naugle, X. Zhang, J. A. Bomser, and J. G. Meszaros Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1131 - H1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. V. Mukhin, M. N. Garnovskaya, M. E. Ullian, and J. R. Raymond ERK Is Regulated by Sodium-Proton Exchanger in Rat Aortic Vascular Smooth Muscle Cells J. Biol. Chem., January 16, 2004; 279(3): 1845 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Buteau, S. Foisy, E. Joly, and M. Prentki Glucagon-Like Peptide 1 Induces Pancreatic {beta}-Cell Proliferation Via Transactivation of the Epidermal Growth Factor Receptor Diabetes, January 1, 2003; 52(1): 124 - 132. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |